70. Novo Nordisk has notched a major legal win against compounding pharmacies that make copies of its diabetes and obesity drug semaglutide, sold under the brand names Ozempic and Wegovy.

Plaintiff Todd Engel pictured with his wife and daughter. A Maryland man who has lost his vision due to non-arteritic anterior ischaemic optic neuropathy (NAION) is suing Novo Nordisk, alleging ...

Ozempic (semaglutide) is a prescription medication approved by the Food and Drug Administration (FDA) for adults with type 2 diabetes. It helps lower blood sugar levels, slow digestion, and ...

Currently Wegovy has a list price of around $1,350 for a 28-day supply. This means that the medication could cost more than $16,000 per year.

The pharmaceutical company that makes the weight-loss drug Wegovy and the diabetes medication Ozempic secured a court victory that limits compounding pharmacies from selling versions of those ...

That would certainly please RFK Jr., who is vehemently opposed to Ozempic, Wegovy, and other weight loss drugs. He says Americans should invest in gym memberships and good nutrition. Then again ...

Novo Nordisk is accused in a suit of failing to warn that weight loss drug Ozempic could cause blindness. The plaintiff, a Maryland man, claims he developed non-arteritic anterior ischemic optic ...

With the incredible weight loss associated with new drugs such as Ozempic and Mounjaro, a whole host of unwanted health side effects have been seen too - one being 'Ozempic mouth'. Others include ...

One hot topic everyone in Hollywood still seems to be talking about that isn't Traylor? Oh-oh-oh Ozempic. Originally marketed for treating Type 2 diabetes, Ozempic—perhaps the most popular of ...